Foresight Capital Management Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Foresight Capital Management Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.77M	Buy	48,144 +11,774	+32%	+$676K	1.35%	36
2026 Q1	$2.21M	Buy	+36,370	New	+$2.12M	1.23%	35

Other funds holding BMY

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Foresight Capital Management Advisors's BMY Position: Q2 2026 in Review

Foresight Capital Management Advisors increased its Bristol-Myers Squibb (BMY) stake by 32% in Q2 2026, buying an estimated $676K and bringing the position to 48,144 shares worth $2.77M. The position accounts for 1.35% of the portfolio, ranked #36.

Foresight Capital Management Advisors first reported a position in BMY in Q1 2026 and has held it in 2 quarters since. 796 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Foresight Capital Management Advisors held 48,144 shares of Bristol-Myers Squibb worth $2.77M as of Q2 2026.
Foresight Capital Management Advisors bought 11,774 Bristol-Myers Squibb shares in Q2 2026, an estimated $676K.
Bristol-Myers Squibb made up 1.35% of Foresight Capital Management Advisors's portfolio in Q2 2026, its #36 holding.
Foresight Capital Management Advisors first reported a position in Bristol-Myers Squibb in Q1 2026 and has held it in 2 quarters since.
796 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Foresight Capital Management Advisors's 13F filing for Q2 2026, filed 8 Jul 2026.